BI-1831169

N/A

Report date: 2026/05/21 20:00:22

Base Information

Drug NameBI-1831169
Drug Alias Nameoncolytic VSV therapyBI-1831169VSV-GP
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[10
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesViratherapeutics Gmbh
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A